| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |